Posted 30 July, 2021
MAXCYTE, INC. IPO completed
IPO completed detected for ticker Nasdaq:MXCT in a 424B4 filed on 30 July, 2021.
This is the U.S. initial public offering of shares of common stock of MaxCyte, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of MAXCYTE, INC.
Health Care/Life Sciences • Biotechnology
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.Market Cap
$484M
View Company Details
$484M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.